Le Lézard
Classified in: Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Horace Mann to announce first-quarter 2024 financial results on May 8


Horace Mann Educators Corporation (NYSE:HMN) plans to release its first-quarter 2024 results on Wednesday, May 8, after the market closes. At that time, the first-quarter Quarterly Report on Form 10-Q, quarterly news release, investor supplement and investor presentation will be available on the company's website at investors.horacemann.com.

Management will host a conference call to discuss the financial results on Thursday, May 9 at noon Eastern Time. Investors can access the call webcast via the Events page of the company's investor site or by dialing 844-735-3325. For the webcast, please log on to the site several minutes in advance to register and download any required audio software. On-demand replay will be available later that day.

About Horace Mann

Horace Mann Educators Corporation is the largest financial services company focused on helping America's educators and others who serve the community achieve lifelong financial success. The company offers individual and group insurance and financial solutions tailored to the needs of the educator community. Founded by Educators for Educators® in 1945, the company is headquartered in Springfield, Illinois. For more information, visit horacemann.com.


These press releases may also interest you

at 07:15
Flow Capital Corp. ("Flow Capital"), a leading provider of flexible growth capital solutions, is pleased to announce the full repayment of a USD 4.5 million investment in an environmental solutions provider. Flow Capital continues to focus on...

at 07:10
bluebird bio, Inc. announced today that it will host a conference call to discuss first quarter 2024 results and business updates on May 9, at 8:00 a.m. ET. To participate in the conference call, please dial +1 (800) 715-9871 (U.S. and Canada) and...

at 07:05
Stoke Therapeutics, Inc. , a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today reported financial results for the first quarter of 2024 and...

at 07:00
Total 1Q 2024 net product revenue of $75.0 million, representing 160% year-over-year growth Auvelity® 1Q 2024 net product sales of $53.4 million, representing 240% year-over-year growth Sunosi® 1Q 2024 net product revenue of $21.6 million...

at 07:00
Brookfield Asset Management ("Brookfield") and Castlelake L.P. ("Castlelake"), an alternatives asset manager specializing in asset-based private credit including aviation and specialty finance, today announced that they have entered into an...

at 07:00
LSL PHARMA GROUP INC. ("the Company" or "LSL Pharma"), a Canadian integrated pharmaceutical company, is pleased to announce that it has entered into a binding Letter of Intent ("LOI") to acquire profitable privately held, Quebec-based competing...



News published on and distributed by: